CVR: 89453119
Previous names: GENSAN HYGIEJNE ApS, GENSAN HYGIEJNE A/S, GENSAN DERMAPHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Peter Bogh and Mikkel Egelund Jensen. The company is owned by DERMAPHARM HOLDING A/S. The company has 120 employees. In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity amounted to DKK 78,142,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er handel, håndværk, industri og anden i forbindelse hermed stående virksomhed
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 122.1 mio. | 28.5 mio. | 154 mio. | 78.1 mio. | 129 | |
| 2024 | 106.3 mio. | 18.5 mio. | 149.5 mio. | 59.6 mio. | 122 | |
| 2023 | 81.3 mio. | 9.6 mio. | 129.8 mio. | 46.6 mio. | 117 | |
| 2022 | 71.2 mio. | 4 mio. | 122.5 mio. | 39.5 mio. | 121 | |
| 2021 | 70.7 mio. | 7.2 mio. | 97.4 mio. | 39.6 mio. | 115 | |
| 2020 | 76.2 mio. | 12 mio. | 85.8 mio. | 40.5 mio. | 108 | |
| 2019 | 63.5 mio. | 6.1 mio. | 84.6 mio. | 32.6 mio. | 105 | |
| 2018 | 52.4 mio. | 4.6 mio. | 86.2 mio. | 30.7 mio. | 91 | |
| 2017 | 47.6 mio. | 8.6 mio. | 64.1 mio. | 31 mio. | 71 | |
| 2016 | 43.2 mio. | 7.8 mio. | 57.6 mio. | 22.4 mio. | 62 | |
| 2015 | 33.3 mio. | 4.3 mio. | 44.5 mio. | 14.6 mio. | 56 | |
| 2014 | 24.2 mio. | -4.3 mio. | 46.8 mio. | 10.3 mio. | - | |
| 2013 | 29.8 mio. | 1.6 mio. | 51.6 mio. | 14.6 mio. | - | |
| 2012 | 19.4 mio. | 1.1 mio. | 60.9 mio. | 15.7 mio. | - |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 87 companies in Fremstilling af parfume, hårshampoo, tandpasta mv.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
DERMA PHARM A/S has published its annual report for 2025. Gross profit came to DKK 122,113,000, and the net result was DKK 28,500,000.
Contact info changed: new phone: 86477744, new email: [email protected] (January 26, 2026).
As of December 18, 2025, Massimiliano Costantini has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Peter Bogh has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Mikkel Egelund Jensen has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Jean-Yves Paul Etienne Desmottes has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Magdalena Jurkiewicz has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Marie Anne Louise Bozec has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Thomas Dimitri Jacquemet has joined the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Michael Vinther has left the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Birger Kuntkes has left the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Brian Lund Mollerup has left the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Kenneth Bo Codam has left the board of directors of DERMA PHARM A/S.
As of October 15, 2025, Christian Skovbo has left the board of directors of DERMA PHARM A/S.
As of August 21, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of DERMA PHARM A/S.
As of August 21, 2025, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of DERMA PHARM A/S.
DERMA PHARM A/S has published its annual report for 2024. Gross profit came to DKK 106,271,000, and the net result was DKK 18,538,000.
DERMA PHARM A/S has published its annual report for 2023. Gross profit came to DKK 81,333,290, and the net result was DKK 9,574,416.
As of September 20, 2023, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of DERMA PHARM A/S.
As of September 20, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of DERMA PHARM A/S.
DERMA PHARM A/S has published its annual report for 2022. Gross profit came to DKK 71,192,456, and the net result was DKK 4,022,422.
DERMA PHARM A/S has published its annual report for 2021. Gross profit came to DKK 70,656,820, and the net result was DKK 7,227,010.
DERMA PHARM A/S has published its annual report for 2020. Gross profit came to DKK 76,154,516, and the net result was DKK 11,970,764.
DERMA PHARM A/S has published its annual report for 2019. Gross profit came to DKK 63,481,838, and the net result was DKK 6,050,671.
DERMA PHARM A/S has published its annual report for 2018. Gross profit came to DKK 52,440,842, and the net result was DKK 4,649,092.
As of November 9, 2018, Christian Skovbo has joined the board of directors of DERMA PHARM A/S.
DERMA PHARM A/S has published its annual report for 2017. Gross profit came to DKK 47,585,869, and the net result was DKK 8,607,895.
DERMA PHARM A/S has published its annual report for 2016. Gross profit came to DKK 43,171,388, and the net result was DKK 7,769,435.
As of April 5, 2017, Peter Bogh is registered as director of DERMA PHARM A/S.
DERMA PHARM A/S has published its annual report for 2015. Gross profit came to DKK 33,330,278, and the net result was DKK 4,334,578.
DERMA PHARM A/S has published its annual report for 2014. Gross profit came to DKK 24,198,762, and the net result was DKK -4,349,813.
DERMA PHARM A/S has published its annual report for 2013. Gross profit came to DKK 29,750,969, and the net result was DKK 1,638,506.
As of November 1, 2013, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of DERMA PHARM A/S.
As of November 1, 2013, Statsautoriseret revisor Søren Cortsen has stepped down as auditor of DERMA PHARM A/S.
DERMA PHARM A/S has published its annual report for 2012. Gross profit came to DKK 19,403,901, and the net result was DKK 1,071,636.
As of January 2, 2012, Statsautoriseret revisor Søren Cortsen has been appointed auditor of DERMA PHARM A/S.
As of January 2, 2012, RÅDGIVNINGSGRUPPEN ApS has stepped down as auditor of DERMA PHARM A/S.
As of January 2, 2012, SC STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of DERMA PHARM A/S.
As of February 25, 2011, SC STATSAUTORISERET REVISIONSANPARTSSELSKAB has been appointed auditor of DERMA PHARM A/S.
As of December 29, 2010, RÅDGIVNINGSGRUPPEN ApS has been appointed auditor of DERMA PHARM A/S.
As of December 29, 2010, SØLYST TOTALENTREPRISE ApS has stepped down as auditor of DERMA PHARM A/S.
As of January 18, 2010, Michael Vinther has joined the board of directors of DERMA PHARM A/S.
As of January 18, 2010, Birger Kuntkes has joined the board of directors of DERMA PHARM A/S.
As of January 18, 2010, Brian Lund Mollerup has joined the board of directors of DERMA PHARM A/S.
As of January 18, 2010, Kenneth Bo Codam has joined the board of directors of DERMA PHARM A/S.
As of January 18, 2010, Carsten Michael Wassini Berger has left the board of directors of DERMA PHARM A/S.
As of January 18, 2010, Kaare Vagner Jensen has left the board of directors of DERMA PHARM A/S.
As of December 1, 2009, DERMAPHARM HOLDING A/S is registered as an owner of DERMA PHARM A/S with an ownership share of 100%.
As of May 9, 2008, SØLYST TOTALENTREPRISE ApS has been appointed auditor of DERMA PHARM A/S.
As of May 9, 2008, VICH 2938 A/S has stepped down as auditor of DERMA PHARM A/S.
As of December 17, 2007, Carsten Michael Wassini Berger has joined the board of directors of DERMA PHARM A/S.
As of December 17, 2007, Kaare Vagner Jensen has joined the board of directors of DERMA PHARM A/S.
As of December 17, 2007, Jan Renneberg has left the board of directors of DERMA PHARM A/S.
As of August 26, 2007, Arndt Østergaard has left the board of directors of DERMA PHARM A/S.
As of August 22, 2007, Sabine Henriette Bendix Gosden has left the board of directors of DERMA PHARM A/S.
As of August 22, 2007, Ove Kloch has left the board of directors of DERMA PHARM A/S.
As of June 7, 2007, Tue Askeland has left the board of directors of DERMA PHARM A/S.
As of April 30, 2007, Ove Kloch has joined the board of directors of DERMA PHARM A/S.
As of September 21, 2006, Sabine Henriette Bendix Gosden has joined the board of directors of DERMA PHARM A/S.
As of September 14, 2006, VICH 2938 A/S has been appointed auditor of DERMA PHARM A/S.
As of September 14, 2006, REVISIONSFIRMAET KVIST OG JENSEN A/S has stepped down as auditor of DERMA PHARM A/S.
As of September 14, 2006, Jan Renneberg has joined the board of directors of DERMA PHARM A/S.
As of September 14, 2006, Tue Askeland has joined the board of directors of DERMA PHARM A/S.
As of September 14, 2006, Jesper Rasmussen has left the board of directors of DERMA PHARM A/S.
As of September 14, 2006, Jens Vindfeldt has left the board of directors of DERMA PHARM A/S.
As of September 14, 2006, Mogens Aaby has left the board of directors of DERMA PHARM A/S.
As of September 14, 2006, Mikkel Egelund Jensen is registered as adm. dir. of DERMA PHARM A/S.
As of September 14, 2006, Arndt Østergaard has stepped down as director of DERMA PHARM A/S.
As of October 6, 2004, Mogens Aaby has joined the board of directors of DERMA PHARM A/S.
As of August 27, 2002, Jesper Rasmussen has joined the board of directors of DERMA PHARM A/S.
As of August 27, 2002, Torsten Viborg Pedersen has left the board of directors of DERMA PHARM A/S.
As of May 31, 2001, REVISIONSFIRMAET KVIST OG JENSEN A/S has been appointed auditor of DERMA PHARM A/S.
As of May 31, 2001, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of DERMA PHARM A/S.
As of May 31, 2001, Torsten Viborg Pedersen has joined the board of directors of DERMA PHARM A/S.
As of May 31, 2001, Paul Busk Jensen has left the board of directors of DERMA PHARM A/S.
As of June 14, 1999, Jens Vindfeldt has joined the board of directors of DERMA PHARM A/S.
As of February 10, 1999, Poul Erik Bæk has joined the board of directors of DERMA PHARM A/S.
As of February 10, 1999, Erik Hjortkjær Andersen has left the board of directors of DERMA PHARM A/S.
As of January 15, 1999, Poul Erik Bæk has left the board of directors of DERMA PHARM A/S.
As of September 22, 1998, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of DERMA PHARM A/S.
As of September 22, 1998, has stepped down as auditor of DERMA PHARM A/S.
As of December 5, 1997, Paul Busk Jensen has joined the board of directors of DERMA PHARM A/S.
As of December 5, 1997, Erik Ejaas Zachariassen has left the board of directors of DERMA PHARM A/S.
As of April 24, 1996, Erik Hjortkjær Andersen has joined the board of directors of DERMA PHARM A/S.
As of April 24, 1996, Erik Ejaas Zachariassen has joined the board of directors of DERMA PHARM A/S.
As of April 24, 1996, Inge Østergaard has left the board of directors of DERMA PHARM A/S.
As of April 24, 1996, Betinna Østergaard has left the board of directors of DERMA PHARM A/S.
On January 24, 1996, the company changed its name from GENSAN DERMAPHARM A/S to DERMA PHARM A/S.
On September 3, 1994, the company changed its name from GENSAN HYGIEJNE A/S to GENSAN DERMAPHARM A/S.
As of September 2, 1994, has stepped down as auditor of DERMA PHARM A/S.
On April 11, 1987, the company changed its name from GENSAN HYGIEJNE ApS to GENSAN HYGIEJNE A/S.
As of February 22, 1980, has been appointed auditor of DERMA PHARM A/S.
As of February 22, 1980, has been appointed auditor of DERMA PHARM A/S.
As of February 22, 1980, Inge Østergaard has joined the board of directors of DERMA PHARM A/S.
As of February 22, 1980, Arndt Østergaard has joined the board of directors of DERMA PHARM A/S.
As of February 22, 1980, Betinna Østergaard has joined the board of directors of DERMA PHARM A/S.
As of February 22, 1980, Arndt Østergaard is registered as director of DERMA PHARM A/S.
DERMA PHARM A/S was founded on February 22, 1980.